Literature DB >> 21922143

Facial basal cell carcinoma: analysis of recurrence and follow-up strategies.

Leonardo Sartore1, Luca Lancerotto, Michela Salmaso, Giorgio Giatsidis, Omar Paccagnella, Mauro Alaibac, Franco Bassetto.   

Abstract

Rates of recurrence after incomplete surgical excision of basal cell carcinoma (BCC) range from 4 to 16.6% of analyzed cases. The aim of the present study was to identify the predictive factors associated with facial BBC recurrence following excision and their influences, in order to establish a proper therapeutic strategy. A monocentric retrospective study was performed reviewing all BCCs surgically excised at the Institute of Plastic Surgery, University of Padua, with particular focus on the involvement of surgical margins and recurrence. Seven hundred and nineteen lesions in 605 patients were studied. Correlations between recurrence probability and various characteristics of BCC were analyzed using a logistic regression model. It was observed that incomplete excision, deep margin involvement, the presence of sclerodermiform or metatypic basaloid squamous cells, as well as pleomorphous histological variants and/or peritumoral inflammatory infiltrates, were all related to an increase in the probability of recurrence. BCC excision must be followed by individualized management with particular consideration for the localization, the histological type and other known predisposing factors; the treatment strategy and, in particular, the length of the surveillance period and the frequency of patient assessment should be evaluated on the basis of the recurrence probability outlined.

Entities:  

Mesh:

Year:  2011        PMID: 21922143     DOI: 10.3892/or.2011.1453

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Plamen Kolev Penev; Julian Ananiev; Andreas Nowak; Yousef Bayyoud; Stanislav Philipov; José-Carlos Cardoso; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-10-02

2.  Multispectral autofluorescence dermoscope for skin lesion assessment.

Authors:  Renan Arnon Romano; Ramon Gabriel Teixeira Rosa; Ana Gabriela Salvio; Javier A Jo; Cristina Kurachi
Journal:  Photodiagnosis Photodyn Ther       Date:  2020-03-02       Impact factor: 3.631

3.  Clinical usefulness of high-frequency ultrasonography in the monitoring of basal cell carcinoma treatment effects.

Authors:  Magdalena Raszewska-Famielec; Adam Borzêcki; Dorota Krasowska; Grażyna Chodorowska
Journal:  Postepy Dermatol Alergol       Date:  2020-07-16       Impact factor: 1.837

Review 4.  Skin cancers and dermal substitutes: Is it safe? Review of the literature and presentation of a 2-stage surgical protocol for the treatment of non-melanoma skin cancers of the head in fragile patients.

Authors:  Marco Marcasciano; Marco Mazzocchi; Juste Kaciulyte; Noemi Spissu; Donato Casella; Diego Ribuffo; Luca Andrea Dessy
Journal:  Int Wound J       Date:  2018-06-04       Impact factor: 3.315

5.  Basal cell carcinoma of the head and neck region: a retrospective analysis of completely excised 331 cases.

Authors:  Duriye Deniz Demirseren; Candemir Ceran; Berrak Aksam; Mustafa Erol Demirseren; Ahmet Metin
Journal:  J Skin Cancer       Date:  2014-04-17

6.  Fourth Dimension in Reconstruction of Defects Following Excision of Basal Cell Carcinoma of Head and Neck!

Authors:  Kandasamy Mahadevan; Sridhar Sruthi; Shanmugam Sridevi; Rajamanoharan Vivek
Journal:  J Cutan Aesthet Surg       Date:  2018 Jul-Sep

7.  Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland.

Authors:  Anna Płaszczyńska; Robert Skibiński; Martyna Sławińska; Wojciech Biernat; Aleksandra Lesiak; Roman J Nowicki; Michał Sobjanek
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

8.  Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma.

Authors:  Mateusz P Szewczyk; Jakub Pazdrowski; Aleksandra Dańczak-Pazdrowska; Paweł Golusiński; Ewa Majchrzak; Lukasz Luczewski; Sławomir Marszałek; Wojciech Silny; Wojciech Golusiński
Journal:  Postepy Dermatol Alergol       Date:  2014-06-13       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.